Literature DB >> 33453605

Non-rodent animal models of osteosarcoma: A review.

Sommer Jarvis1, Evgenia Koumadoraki2, Nikolaos Madouros2, Shayka Sharif2, Amber Saleem2, Safeera Khan2.   

Abstract

Osteosarcoma is extremely malignant, and the most common cancer that affects bone. Current treatments involve surgical resection of the affected area and multi-agent chemotherapy, though survival rate is generally poor for those affected by metastases. As treatment for osteosarcoma has remained unchanged for the past few decades, there is a need for further advancements in the understanding of osteosarcoma biology and therapeutics. Thus, reliable animal models that can accurately recapitulate the disease are required. Though rodents represent the most popular animal model of osteosarcoma, they may not model the disease best. This review analyzes emerging alternative non-rodent animal models of osteosarcoma, such as the chick chorioallantoic membrane (CAM) assay, pigs, and canines. Each of these alternatives offer advantages over classic rodent models for pre-clinical research. Research of these cross-species platforms imparts knowledge of metastases biology and potential new treatments for osteosarcoma.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Cam assay; Canine; Osteosarcoma; Pig; Pre-clinical research

Mesh:

Year:  2021        PMID: 33453605     DOI: 10.1016/j.ctarc.2021.100307

Source DB:  PubMed          Journal:  Cancer Treat Res Commun        ISSN: 2468-2942


  1 in total

1.  Osteogenic and anti-tumor Cu and Mn-doped borosilicate nanoparticles for syncretic bone repair and chemodynamic therapy in bone tumor treatment.

Authors:  Libin Pang; Renliang Zhao; Jing Chen; Jingxin Ding; Xiaochen Chen; Wenwen Chai; Xu Cui; Xiaolin Li; Deping Wang; Haobo Pan
Journal:  Bioact Mater       Date:  2021-10-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.